Ngā hua rapu - Yehia I. Abugabal
- E whakaatu ana i te 1 - 5 hua o te 5
-
1
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade mā David J. Pinato, Takahiro Kaneko, Anwaar Saeed, Tiziana Pressiani, Ahmed O. Kaseb, Yinghong Wang, David Szafron, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh Naqash, Mahvish Muzaffar, Musharraf Navaid, Chieh-Ju Lee, Anushi Bulumulle, Bo Yu, Sonal Paul, Neil Nimkar, Dominik Bettinger, Hannah Hildebrand, Yehia I. Abugabal, Celina Ang, Thomas U. Marron, Uqba Khan, Nicola Personeni, Lorenza Rimassa, Yi‐Hsiang Huang
I whakaputaina 2020Artigo -
2
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study mā Petros Fessas, Ahmed O. Kaseb, Yinghong Wang, Anwaar Saeed, David Szafron, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh Naqash, Mahvish Muzaffar, Musharraf Navaid, Uqba Khan, Chieh-Ju Lee, Anushi Bulumulle, Bo Yu, Sonal Paul, Neil Nimkar, Dominik Bettinger, Francesca Benevento, Hannah Hildebrand, Tiziana Pressiani, Yehia I. Abugabal, Nicola Personeni, Yi‐Hsiang Huang, Lorenza Rimassa, Celina Ang, Thomas U. Marron, David J. Pinato
I whakaputaina 2020Artigo -
3
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched s... mā Brett Marinelli, Edward Kim, Antonio D’Alessio, Mario A. Cedillo, Ishan Sinha, Neha Debnath, Masatoshi Kudo, Naoshi Nishida, Anwaar Saeed, Hannah Hildebrand, Ahmed O. Kaseb, Yehia I. Abugabal, Anjana Pillai, Yi‐Hsiang Huang, Uqba Khan, Mahvish Muzaffar, Abdul Rafeh Naqash, Rahul Patel, A. Fischman, V. Bishay, Dominik Bettinger, Max W. Sung, Celina Ang, Myron Schwartz, David J. Pinato, Thomas U. Marron
I whakaputaina 2022Artigo -
4
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma mā Petros Fessas, Muntaha Naeem, Matthias Pinter, Thomas U. Marron, David Szafron, Lorenz Balcar, Anwaar Saeed, Tomi Jun, Sirish Dharmapuri, Anuhya Gampa, Yinghong Wang, Uqba Khan, Mahvish Muzaffar, Musharraf Navaid, Pei‐Chang Lee, Anushi Bulumulle, Bo Yu, Sonal Paul, Neil Nimkar, Dominik Bettinger, Hannah Hildebrand, Yehia I. Abugabal, Tiziana Pressiani, Nicola Personeni, Naoshi Nishida, Masatoshi Kudo, Ahmed O. Kaseb, Yi‐Hsiang Huang, Celina Ang, Anjana Pillai, Lorenza Rimassa, Abdul Rafeh Naqash, Elad Sharon, Alessio Cortellini, David J. Pinato
I whakaputaina 2021Artigo -
5
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma mā Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U. Marron, Tomi Jun, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Musharraf Navaid, Abdul Rafeh Naqash, Anuhya Gampa, Umut Özbek, Junk-Yi Lin, Ylenia Perone, Bruno Vincenzi, Marianna Silletta, Anjana Pillai, Yinghong Wang, Uqba Khan, Yi‐Hsiang Huang, Dominik Bettinger, Yehia I. Abugabal, Ahmed O. Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Luca Di Tommaso, Masatoshi Kudo, Arndt Vogel, Francesco Mauri, Alessio Cortellini, Rohini Sharma, Antonio D’Alessio, Celina Ang, David J. Pinato
I whakaputaina 2021Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Cancer
Gastroenterology
Hepatocellular carcinoma
Immunotherapy
Internal medicine
Medicine
Oncology
Adverse effect
Nivolumab
Regimen
Surgery
Biochemistry
Biology
Biomarker
Chemistry
Chemotherapy
Clinical trial
Expanded access
Inflammation
Liver cancer
Liver function
Multivariate analysis
Observational study
Overall survival
Paleontology
Portal vein thrombosis
Progression-free survival
Progressive disease
Propensity score matching
Proportional hazards model